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bowel syndrome (IBS) is the most frequent functional gastrointestinal
disorder. It is characterized by abdominal hypersensitivity, leading to
discomfort and pain, as well as altered bowel habits. While it is
common for IBS to develop following the resolution of infectious
gastroenteritis [then termed postinfectious IBS (PI-IBS)], the mecha-
nisms remain incompletely understood. Giardia duodenalis is a cos-
mopolitan water-borne enteropathogen that causes intestinal malab-
sorption, diarrhea, and postinfectious complications. Cause-and-effect
studies using a human enteropathogen to help investigate the mech-
anisms of PI-IBS are sorely lacking. In an attempt to establish
causality between giardiasis and postinfectious visceral hypersensi-
tivity, this study describes a new model of PI-IBS in neonatal rats
infected with G. duodenalis. At 50 days postinfection with G. duo-
denalis (assemblage A or B), long after the parasite was cleared, rats
developed visceral hypersensitivity to luminal balloon distension in
the jejunum and rectum, activation of the nociceptive signaling
pathway (increased c-fos expression), histological modifications (vil-
lus atrophy and crypt hyperplasia), and proliferation of mucosal
intraepithelial lymphocytes and mast cells in the jejunum, but not in
the rectum. G. duodenalis infection also disrupted the intestinal
barrier, in vivo and in vitro, which in turn promoted the translocation
of commensal bacteria. Giardia-induced bacterial paracellular trans-
location in vitro correlated with degradation of the tight junction
proteins occludin and claudin-4. The extensive observations associ-
ated with gut hypersensitivity described here demonstrate that, indeed,
in this new model of postgiardiasis IBS, alterations to the gut mucosa
and c-fos are consistent with those associated with PI-IBS and, hence,
offer avenues for new mechanistic research in the field.
Giardia; irritable bowel syndrome; visceral hypersensitivity; bacterial
translocation; tight junctions
THE INTESTINAL PROTOZOAN PARASITE Giardia duodenalis (syn. G.
lamblia, G. intestinalis) infects a wide array of mammalian
species, including humans. Giardiasis is one of the most
common water-borne parasitic infections of the human intes-
tine, and its acute clinical symptoms include intestinal malab-
sorption and diarrhea (14, 81). The prevalence of giardiasis
ranges from 20% to 100% in developing countries and from
3% to 7% in industrialized nations (68). G. duodenalis is
divided into eight distinct genetic assemblages (i.e., assem-
blages A–H). While only assemblages A and B are pathogenic
to humans, they can also infect nonhuman mammalian species,
thus highlighting the zoonotic potential of this parasite (11).
The pathophysiology of giardiasis is multifactorial and in-
volves host and parasite factors, as well as immunological and
nonimmunological mucosal processes (23). In addition to acute
symptoms, Giardia infections have also been associated with
ocular pathologies, arthritis, failure to thrive, stunting, growth
retardation, and cognitive impairment in children (33). Giar-
diasis can also lead, postinfectiously, to chronic diseases, such
as chronic fatigue syndrome and functional gastrointestinal
(GI) disorders, via unknown mechanisms (33).
Irritable bowel syndrome (IBS) is the most common func-
tional GI disorder in industrialized countries (41, 51). It is
characterized by abdominal pain and discomfort and alteration
of bowel habits. IBS manifests in the absence of overt under-
lying pathology or biomarkers, although low-grade inflamma-
tion has been proposed as a contributing factor (15). In some
patients, IBS may arise following infectious gastroenteritis
(e.g., with Campylobacter jejuni, Escherichia coli, Salmonella
spp., or even viral enteritis) (7, 54, 55). Recent studies have
also associated protozoan parasites such as G. duodenalis or
Cryptosporidium sp. with the onset of postinfectious IBS
(PI-IBS) (35, 46). It is estimated that 7–31% of patients with
infectious gastroenteritis go on to develop PI-IBS (34). PI-IBS
has also been shown to occur long after clearance of the
inciting pathogen. The risk of developing IBS increases sixfold
after GI infections and remains elevated for several years after
infection, further underscoring the significant potential for
these symptoms to occur over the long term (36, 54, 76).
Nevertheless, a cause-and-effect relationship has yet to be
established experimentally in a model using a human entero-
pathogen known to cause PI-IBS. Recently, after an outbreak
of giardiasis in Bergen, Norway, numerous cases of chronic
fatigue and IBS (with diarrheal subtype) and functional dys-
pepsia were reported in the infected population (35). Several
pathophysiological mechanisms, including visceral hypersen-
sitivity (3), central nervous system dysregulation (1), and GI
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motility abnormalities (9, 45), have been associated with the
pathogenesis of IBS. Increased intestinal permeability and
changes in microbiota composition have also been reported in
some of these patients (43). However, the biological basis of
PI-IBS remains incompletely understood.
The aim of the present study was to develop an animal
model enabling the demonstration of causality between giar-
diasis and PI-IBS and to further describe, in this model,
abnormalities that have been associated with postinfectious
visceral hypersensitivity in humans. In turn, such a model
could be used to study postgiardiasis IBS and the underlying
mechanisms in its pathogenesis. Using a novel neonatal rat
model, we established that infection with G. duodenalis assem-
blage A or B can lead to visceral hypersensitivity in the
jejunum, as well as in the rectum, 50 days postinfection (PI), at
which time the parasite has been completely cleared from the
host. In this model, postinfectious jejunal hypersensitivity was
associated with villus atrophy and crypt hyperplasia and in-
creased mucosal intraepithelial lymphocytes (IELs) and mast
cells. In contrast, rectal hypersensitivity occurred in the ab-
sence of detectable changes in IELs or mast cells. During the
acute stage of infection, Giardia facilitated the translocation of
commensal bacteria and activated the expression of nocicep-
tive c-fos in the spinal dorsal horn that received sensory input.
Additional mechanistic experiments demonstrated that Giar-
dia-induced bacterial translocation was primarily paracellular
and implicated disruption of the tight junction proteins occlu-
din and claudin-4.
METHODS AND MATERIALS
G. duodenalis Isolates
Giardia trophozoites were maintained axenically or excysted
through passage in gerbils (Meriones unguculatus). Two different
assemblages (A and B), one isolate per assemblage (WB and H3,
respectively), were used.
WB trophozoites [WB; genotype A, catalog no. 30957, American
Type Culture Collection (ATCC)-LGC Promochem, Molsheim,
France] were maintained in axenic cultures in Keister’s modified
TYI-S-33 medium (24, 44).
H3 isolates (HB; water-borne, P101, New Orleans, LA, cysts of G.
lamblia, human isolate H-3, aka CH-3) were obtained by excystation
through passage in gerbils. Gerbils were orally infected with a
suspension of 103 cysts. At 7 days PI, gerbils were euthanized by
intraperitoneal injection of a lethal dose of pentobarbitone sodium
(Abbott Diagnostic, Rungis, France). After laparotomy, the duodenum
and jejunum were sampled, and parasites were extracted, counted, and
diluted for infection.
Animal Model Infection
Five-day-old suckling Sprague-Dawley rats and their mother (Jan-
vier, Le Genest Saint Isles, France) were maintained under pathogen-
free conditions and given food and water ad libitum. Suckling rats
were orally infected with 104 live Giardia trophozoites in 100 l of
TYI-S-33 medium: 30 rats were infected with WB, and 30 rats were
infected with H3. Vehicle-treated animals (n 20) were gavaged with
vehicle (100 l of TYI-S-33 medium). Animals were handled accord-
ing to the regulations enforced by the French Ministry of Agriculture,
the University Ad Hoc Ethical Committee (which aproved the proto-
col), and the Canadian Council of Animal Care. Rats were studied at
7 days PI (peak of infection), 21 days PI (clearance), and 50 days PI
(postinfectious period).
Assessment of Visceral Hypersensitivity to Balloon Distension
Jejunal and rectal sensitivity to balloon distension was tested in 15
rats from each group at 50 days PI, as previously described (46, 57).
Sex distribution within the groups was as follows: 9 females and 8
males in the vehicle-treated group, 9 males and 4 females in the
WB-infected group, and 14 males and 4 females in the H3-infected
group. Rats were anesthetized with pentobarbitone sodium (Pentobar-
bital Sodique, Ceva Santé Animale, Libourne, France; 6 mg/kg ip).
The ventral neck was incised to expose the trachea, in which an
incision was made, and a tube was inserted and fixed to allow smooth
breathing throughout the experiment. A midline abdominal incision
was made to expose the small intestine. At 7 cm from the ligament of
Treitz, an incision was made on the antimesenteric side of the
jejunum, in which a balloon was inserted and fixed. The intestinal
segment was returned to the peritoneal cavity, which was sutured (2-0
Ercylene II, Sherwood Davis & Geck, Bondoufle, France). Rectal
distensions were performed by insertion of a balloon via the anal
route. Balloons were arterial embolectomy catheters (5F, 10 mm
diameter, 80 cm long; Fogarty-Edwards Life Sciences, Saint-Priex,
Switzerland). Distensions in the jejunum and rectum were performed
in a stepwise fashion (from 0.1 to 0.4 ml and from 0.2 to 1.0 ml,
respectively). Twenty-second distensions were followed by a 5-min
rest period. Blood pressure variation was continuously recorded from
a side-arm carotid cannula with a pressure transducer (model P10EZ,
Gould, Courtaboeuf, France) connected to a window graph 240
(Gould), linked to a data acquisition-and-analysis module (iWorx404,
Bioseb, Vitrolles, France). All data were recorded and analyzed using
LabScribe2 software (Bioseb).
Infection Assessment
At 7 days PI, the presence of G. duodenalis trophozoites in the
intestine was assessed by microscopic observation, and the infecting
assemblage was identified by nested PCR and confirmed by sequenc-
ing (data not shown) (29, 47).
Histology
At 7, 21, and 50 days PI, five rats from each group were euthanized
by a lethal dose of pentobarbitone sodium (Ceva Santé Animale; 50
mg/kg ip). Sections of the duodenum and jejunum were fixed in 10%
formaldehyde solution and embedded in paraffin.
Sections (4 m) were stained with Giemsa stain for analysis. Villus
heights (VH) and crypt depths (CD) were measured on sagittal
sections of 15 villus-crypt units using image analysis software (His-
tolab 6.13.0, Microvision, Evry, France). For each group, the VH-
to-CD ratio was calculated as the mean VH divided by the mean CD.
IELs were labeled in 4-m sections with periodic acid-Schiff
staining and counted per villus for 10 villi in each animal.
Mast cells were stained by immunohistochemistry using monoclo-
nal mouse anti-mast cell tryptase antibody (Abcam, Paris, France) and
horseradish peroxidase (HRP)-conjugated goat anti-mouse secondary
antibody (ultraView Universal DAB Detection Kit, Ventana, Roche,
Boulogne-Billancourt, France). Mast cells were counted per villus for
100 villi in each animal.
Assessment of c-fos Expression
At 7, 21, and 50 days PI, in five rats per group, c-fos expression was
assessed in fresh spinal cord samples by RT-quantitative PCR using a
previously validated approach (40). Spinal cord sections between T10
and L2 were frozen in RNAlater (Qiagen) and stored at 70°C until
RNA extraction. RNA extractions and reverse transcription were
performed on 20 mg of spinal cord following the manufacturer’s
instructions (RNeasy Mini Kit and QuantiTect Reverse Transcription
Kit, Qiagen). Quantitative real-time PCRs were carried out in a
thermocycler (Rotor-Gene Q) at 60°C (QuantiFast SYBR Green PCR
kit, Qiagen). We used GAPDH as internal control and targeted the
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gene c-fos (40) (Table 1). Analyses were performed using Rotor-Gene
Q software, and the cycle threshold (2Ct) method was applied to
measure the fold change in mRNA expression between the control and
the infected group (70).
Assessment of Bacterial Translocation In Vivo
Plating. Spleen, liver, and mesenteric lymph nodes (MLNs) were
aseptically removed and homogenized using two 3.2-mm stainless
steel beads (FastPrep-24, MP Biomedical). After homogenization,
samples were plated on Columbia agar containing 5% sheep blood for
2 days at 37°C under aerobic or anaerobic conditions [AnaeroGen
2.5L pack in an AnaeroJar (Oxoid, Thermo Scientific)], and colony-
forming units (CFUs) were enumerated. Bacterial counts were stan-
dardized in CFUs per gram of tissue.
Fluorescence in situ hybridization. Segments of colon were fixed in
4% paraformaldehyde overnight and embedded in paraffin. For fluo-
rescence in situ hybridization (FISH), tissue was hybridized with a
universal bacterial 16S fluorescent rRNA probe (EUB338-Cy3,
5=GCTGCCTCCCGTAGGAGT-Cy3, AlphaDNA, Montreal, PQ,
Canada) at 10 ng/l and a control negative probe (NEUB338-Cy3,
5=ACTCCTACGGGAGGCAGC-Cy3, AlphaDNA) at 5 ng/l and
immunostained for DNA by 4=,6-diamidino-2-phenylindole (Sigma-
Aldrich). Images were acquired with a Leica DMR fluorescence
microscope.
Cell Culture
Caco-2 human colonic epithelial cells (passages 26–36, HTB-37,
ATCC) were grown in minimum essential medium with 1 Earle’s
salt (MEME; Sigma-Aldrich, Oakville, ON, Canada) containing 20%
fetal bovine serum, 200 mM L-glutamine, 100 U/ml penicillin, 100
U/ml streptomycin, and 100 mM sodium pyruvate and incubated at
37°C and 5% CO2. For translocation studies, cells were seeded at 104
cells/ml onto Transwell filters [12-mm filter with 3.0-m pore poly-
carbonate membrane insert (Costar, Corning, NY)]. Transepithelial
electrical resistance (TER) was monitored with an electrovoltohmeter
(World Precision Instruments, Sarasota, FL), and monolayers were
used at confluence (TER 400 ). For internalization assay, cells
were seeded at 104 cells/ml onto flat-bottom plates (BD BioCoat,
Becton Dickinson Biosciences, Mississauga, ON, Canada).
Assessment of Bacterial Translocation In Vitro
Monolayers were used in antibiotic-free MEME to the apical and
basolateral compartments of the Transwell system. Monolayers were
infected apically in the presence or absence of G. duodenalis assem-
blage A at a multiplicity of infection (MOI) of 101 trophozoites/
enterocyte and in the presence or absence of E. coli HB101 at a MOI
of 100 CFUs/enterocyte (4 groups: vehicle, Giardia, E. coli, and
Giardia 	 E. coli). After 1, 2, 3, and 6 h of incubation in aerobic
conditions, E. coli recovered in the basolateral compartment were
enumerated by spreading serial dilutions onto nonselective Luria
broth (LB) agar and aerobic incubation overnight at 37°C.
Assessment of Bacterial Internalization
After coinfection, monolayers were incubated for 1 h with MEME
20% containing gentamicin (250 g/ml; Sigma-Aldrich) and lysed
with RIPA buffer (1% Igepal, 0.1% SDS, and 0.5% sodium deoxy-
cholate in PBS) containing a protease inhibitor (Complete Mini,
Roche Diagnostic, Indianapolis, IN; 1 tablet/10 ml). Viable bacteria
were enumerated by spreading onto nonselective LB agar. A prelim-
inary experiment confirmed that surface E. coli were killed by the
gentamicin treatment: for each condition (vehicle, Giardia, E. coli,
and Giardia 	 E. coli), serial dilutions of the supernatant after 1 h of
incubation with gentamicin were plated on LB agar; no bacteria were
observed after 24 h of incubation at 37°C (data not shown).
Immunoblotting of Tight Junction Proteins
Protein concentrations from lysates of cell monolayers were as-
sessed by Bradford assay (DC protein assay kit, Bio-Rad Laborato-
ries, Hercules, CA). Protein concentration was normalized at 3 mg/ml.
Samples were diluted 1:1 in 2 Laemmli buffer before Western
blotting. Temporary Ponceau red S staining was used to verify the
transfer efficiency, as well as the loading, of proteins (67). Membranes
were then immunostained for occludin and claudin-4 with rabbit
polyclonal anti-claudin-4 antibody (0.2 g/ml; Abcam) or mouse
monoclonal anti-occludin antibody (0.5 g/ml; Invitrogen) overnight
at 4°C under agitation. HRP-conjugated rat anti-rabbit IgG (1:1,000
dilution) in Tris-buffered saline-Tween 20 with 5% dry milk or
HRP-conjugated goat anti-mouse IgG (1:1,000 dilution) was used as
secondary antibody. Bands were visualized using the ECL Plus
Western blotting detection system (GE Healthcare, Pittsburgh, PA).
Statistical Analysis
Values are means 
 SE. Comparison between groups was evalu-
ated using t-test, Mann-Whitney test, Kruskall-Wallis-Newman test,
or one- or two-way ANOVA, depending on the data distribution and
experimental setup. P  0.05 at 95% confidence interval was consid-
ered significant.
RESULTS
G. duodenalis Induces Visceral Hypersensitivity at 50 Days
PI in Immunocompetent Rats
Measurements of visceral hypersensitivity are among the
main features of IBS and have been used in models of PI-IBS
and postinflammatory IBS (9, 46). For an accurate and repro-
ducible identification of visceral hypersensitivity in animal
models, most experts in the field rely on a barostat technique
using balloon distension (19). Consistent with this approach,
we measured blood pressure upon intraluminal balloon disten-
sion, as a drop in cardiovascular pressure is predictive of
visceral nociception (50, 69).
At 50 days PI, the drop in blood pressure was significantly
increased in assemblage A-infected compared with vehicle-
treated rats in response to distension volumes of 0.3 and 0.4 ml
in the jejunum (Fig. 1A). A similar trend was observed in the
rectum at distension volumes of 0.6, 0.8, and 1 ml (Fig. 1B).
Visceral hypersensitivity was detected in 12 of 19 animals
tested (7 of 9 males and 4 of 4 females).
At 50 days PI, the drop in blood pressure was significantly
higher in assemblage B-infected than vehicle-treated rats start-
Table 1. Primer sequences of GAPDH and c-fos
Target Gene
Sequences
PCR
Product Size
Annealing
Temperature, °CForward Reverse
GAPDH 5=-GGAAAGCTGTGGCGTGATTGG-3= 5=-GTAGGCCATGAGGTCCACCA-3= 414 60
c-fos 5=-AACCATCCCCGAAATCCTAC-3= 5=-AGCGGAACAGAGAAACTGGA-3= 185 60
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ing at 0.1 ml of distension (Fig. 1C). Similarly, in the rectum,
the drop in blood pressure was significantly higher in infected
than vehicle-treated rats starting at 0.2 ml of distension (Fig.
1D). Visceral hypersensitivity was observed in 10 of 18 ani-
mals tested (7 of 14 males and 3 of 4 females).
G. duodenalis Infection Induces Modification of the Mucosal
Architecture
Several host species have been shown to exhibit intestinal
villus atrophy and crypt hyperplasia, as well as microvillus
atrophy, in response to giardiasis (13, 14). We assessed the
mucosal architecture in the duodenum and jejunum of animals
at 7, 21, and 50 days PI.
Duodenal villus length of assemblage A- and B-infected rats
was reduced at 50 days PI (Fig. 2A).
Crypt length was increased in the duodenum of assemblage
B-infected rats at 7 and 21 days PI and assemblage A-infected
rats at 21 days PI compared with vehicle-treated rats (Fig. 2B).
Overall villus-to-crypt ratios in the duodenum remained un-
changed at each time point (Fig. 2C).
Crypt length in the jejunum of assemblage B-infected rats
was increased at 21 days PI (Fig. 2E). No other significant
changes were observed in the jejunal architecture of assem-
blage A- and B-infected rats compared with vehicle-treated rats
(Fig. 2, D–F).
G. duodenalis Increases Mucosal IELs and Mucosal Mast
Cells at 50 Days PI in the Jejunum, but not in the Rectum
Colonic mast cell infiltration and degranulation in proximity to
mucosal innervations have been suggested as a contributing factor
to abdominal pain in IBS (5). IELs have also been shown to be
increased in some tissues from patients with IBS, but not in others
(74, 78). We assessed mast cell and IEL numbers in the jejunum
and rectum of experimental animals. At 50 days PI, a significant
increase in IEL and mucosal mast cell numbers was observed in
the jejunum of assemblage A- and B-infected compared with
vehicle-treated rats (Figs. 3B and 4B). No significant changes
were observed at 7 days PI for either assemblage (Figs. 3A and
4A). In the rectum, where IEL and mast cell numbers were low, no
significant differences were observed upon infection with either
Giardia assemblage (Figs. 3C and 4C).
G. duodenalis Infection Induces c-fos Expression in the
Spinal Dorsal Horn
The protooncogene c-fos is a marker of neuronal activity in
the spinal neurons that receive sensory input. Neuronal expres-
sion of c-fos was shown to be increased in animal models of
visceral pain and IBS (82). To further evaluate whether Giar-
dia infection could induce the activation of spinal neurons, we
assessed c-fos mRNA expression in Giardia-infected animals.
Fig. 1. Giardia duodenalis assemblages A and B induce visceral hypersensitivity in the jejunum and rectum at 50 days postinfection (PI): assessment of the
decrease in carotid artery blood pressure in control and Giardia-infected animals during jejunal and rectal balloon distensions. A and B: jejunal and rectal
sensitivity to distension at 50 days PI using G. duodenalis assemblage A (strain WB). C and D: jejunal and rectal sensitivity to distension at 50 days PI using
G. duodenalis assemblage B (strain H3). Values are means 
 SE (n  20 in each group). *P  0.05, **P  0.01, and ***P  0.001 vs. vehicle-treated (by
Student’s t-test and Newman-Keuls test).
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At 7, 21, and 50 days PI, the mRNA expression levels of c-fos
in the spinal cord were significantly increased in assemblage
A-infected compared with vehicle-treated rats (Fig. 5).
Giardia Assemblage A Induces Translocation of Commensal
Bacteria In Vivo
Microbiota play an important role in health and disease (72),
and we recently demonstrated that Giardia infection alters the
host microbiota at a structural and compositional level (6). In
addition, our group previously demonstrated that another enteric
pathogen, C. jejuni, was able to induce bacterial translocation (42). In
an attempt to identify factors that may contribute to the appearance of
visceral hypersensitivity, we tested whether G. duodenalis could
facilitate the translocation of commensal bacteria through the intes-
tinal epithelium during the acute phase of infection.
The present findings illustrate that Giardia infection pro-
motes the translocation of commensal bacteria to the spleen
and liver at 7 days PI, an effect that was lost at 21 and 50 days
PI (Fig. 6).
We observed a thinning of the mucus layer accompanied by
bacterial infiltration in our infected animals at 7, 21, and 50
days PI, while the normal colonic structure was maintained in
vehicle-treated animals. Although bacterial translocation was
not observed in the spleen and liver at 21 and 50 days PI,
observations of the colonic mucosal structure showed infiltra-
tion maintained at 21 and 50 days PI in the colonic mucosa of
Giardia-infected rats (Fig. 7).
Giardia Induces Translocation of Noninvasive E. coli Through
Caco-2 Monolayers and Tight Junction Protein Degradation
The mechanisms of Giardia-induced bacterial translocation
were further characterized in Caco-2 cell monolayers grown on
Transwell filters. Translocation of E. coli HB101 induced by
Giardia was assessed at 1, 2, 3, and 6 h PI.
Fig. 2. Giardia assemblages A and B induce mucosal architecture modifications in the duodenum and jejunum at 7, 21, and 50 days (D7, D21, and D50) PI:
measure of crypt and villus length of the duodenal and jejunal mucosa of vehicle-treated and Giardia-infected animals at 7, 21, and 50 days PI after Giemsa
staining on 15 well-oriented villus-crypt units. A and B: average villus and crypt length in the duodenum of rats at 7, 21, and 50 days PI. C and F: average ratio
of villus height to crypt depth in the duodenum and jejunum of rats at 7, 21, and 50 days PI. D and E: average villus and crypt length in the jejunum of rats
at 7, 21, and 50 days PI. Values are means 
 SE (n  10 in each group). *P  0.05 and **P  0.01 (by ANOVA and Tukey’s test).
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After 2, 3, and 6 h of incubation, while following similar
patterns over the various time points, E. coli translocation was
significantly increased (P  0.05) in G. duodenalis- compared
with vehicle-treated monolayers (Fig. 8). In an attempt to
determine whether bacteria translocated via the transcellular
route in a mechanism reminiscent of that recently observed in
C. jejuni infection (42), a gentamicin assay was performed on
Caco-2 cells grown to confluence exposed to G. duodenalis
assemblage A and E. coli HB101. At the time of translocation,
there were no significant differences in intracellular bacterial
numbers between the cells treated with E. coli alone and those
treated with both Giardia and E. coli (Fig. 9).
Additional experiments determined whether Giardia-in-
duced bacterial translocation was associated with disruptions
of the tight junction proteins occludin and claudin-4. We
observed that G. duodenalis induces a reduction in occludin
and claudin-4 protein levels in whole lysates at 1, 2, 3, and 6
h PI (Figs. 10 and 11).
Fig. 3. Giardia induces an increase in intraepithelial lymphocytes (IELs) in the jejunum, but not in the rectum, of rats at 50 days PI with assemblage A or B:
count of IELs in the jejunal mucosa of the vehicle-treated and Giardia-infected rats at 7 and 50 days PI after immunostaining with periodic acid-Schiff on 10
villi. A and B: average number of IELs per enterocyte in the jejunum of rats at 7 and 50 days PI. C: average number of IELs per enterocyte in the rectum of
rats at 50 days PI. Values are means 
 SE (n  10 in each group). ****P  0.0001 vs. vehicle-treated (by ANOVA and Tukey’s test).
Fig. 4. Giardia induces mast cell infiltration in the jejunum, but not in the rectum, of rats at 50 days PI with assemblage A or B: count of mucosal mast cells
after immunohistochemistry marking with a mast cell tryptase-directed antibody in the jejunum and rectum of control and Giardia-infected rats at 7 and 50 days
PI on 100 villi. A and B: mucosal mast cell counts per villus in the jejunum of rats from each group (vehicle-treated, infected with assemblage A, and infected
with assemblage B) at 7 and 50 days PI. C: mucosal mast cell counts per villus in the rectum of rats from each group at 50 days PI. Values are means 
 SE
(n  10 in each group). **P  0.01 vs. vehicle-treated (by ANOVA and Tukey’s test).
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DISCUSSION
IBS may arise following acute enteritis with bacteria such as
E. coli, C. jejuni (55, 77), and Salmonella spp. (58), viral
enteropathogens (53), or parasites such as Giardia or Crypto-
sporidium (35, 46). A better understanding of the mechanisms
by which this may occur is sorely warranted, and animal
models for PI-IBS representative of the human pathology and
using human pathogens are lacking. The recent outbreak in
Bergen, Norway, underscored the significant potential of the
parasite G. duodenalis to cause PI-IBS and lead to long-term
GI symptoms. Using a novel Giardia-induced postinfectious
model and in vitro mechanistic studies, the present study
establishes, for the first time, a cause-and-effect relationship
between giardiasis and postinfectious intestinal hypersensitiv-
ity with Giardia assemblage A or B. Consistent with clinical
presentations in the human host, visceral hypersensitivity was
observed in the small intestine as well as in the rectum, an area
remote from any active colonization by the parasite. Hyper-
sensitivity in the jejunum coincided with reduced VH, crypt
hyperplasia, and increased mucosal IELs and mast cells. In the
rectum, however, hypersensitivity could be measured in the
absence of abnormal IEL or mast cell counts, again consistent
with human presentations of PI-IBS that may occur in the
presence of only mild inflammatory infiltration (2, 15). Starting
in the acute phase of infection, Giardia facilitated the translo-
cation of commensal bacteria and induced the expression of the
protooncogene c-fos. Bacterial infiltration and c-fos expression
were shown to persist in the postinfectious stage. In vitro
findings indicate that Giardia-induced bacterial translocation is
primarily paracellular, rather than transcellular, and implicate
the degradation of tight junction proteins, including occludin
and claudin-4.
Visceral hypersensitivity occurs in up to 80–90% of patients
with IBS (60, 66) and has been reported throughout the GI
tract, including the rectum (60), colon (27), jejunum (25), and
Fig. 5. Expression of c-fos mRNA in thoracolumbar spinal cord of Giardia-
infected rats was significantly higher at 7, 21, and 50 days PI: expression of c-fos
mRNA in thoracolumbar spinal cord segments of rats (control vs. Giardia-
infected) at 7, 21, and 50 days PI. Values are means
 SE (n 10 in each group).
*P  0.05 vs. vehicle-treated (by Student’s t-test and Newman-Keuls test).
Fig. 6. Giardia-infected animals showed a significant translocation of commensal bacteria through the intestinal epithelium in liver and spleen during the acute
stage of the disease: bacterial counts were examined in spleen and liver of vehicle-treated and Giardia-infected animals at 7, 21, and 50 days PI. A and B: bacterial
translocation in spleen and liver at 7, 21, and 50 days PI in aerobic and anaerobic conditions. Values are means 
 SE (n  5 in each group at each time). **P 
0.01 and ***P  0.001 vs. vehicle-treated (by Student’s t-test and Newman-Keuls test).
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esophagus (22). While both Giardia assemblages were able to
cause hyperalgesia, allodynia appeared to be more marked with
assemblage B. In 55% and 63% of rats infected with Giardia
assemblages B and A, respectively, hypersensitivity developed
at 50 days PI. In this model, while rats of both sexes were
similarly represented in all groups, animals from either sex
presented with postinfectious hypersensitivity (16 of 24 males
and 7 of 8 females in the infected groups). Additional studies
using this model system may help establish whether the
degree of postinfectious visceral hypersensitivity following
a transient infection with G. duodenalis may be sex-depen-
dent (35). Indeed, some evidence indicates that sex differ-
ences in IBS symptoms may exist, particularly in industri-
alized countries, and female sex hormones may influence the
severity of IBS (59).
In agreement with a number of previous reports, this study
shows that different Giardia assemblages may cause different
morphological modifications of the intestinal mucosa, depend-
ing on the time and site of the study (8, 17). Strain-dependent
modifications of the mucosal morphology have been described
in acute giardiasis in rats, as well as in other models, and in
human subjects (12, 17). The present findings illustrate that
villus atrophy may also occur at a time coinciding with postin-
fectious visceral hypersensitivity. In a number of intestinal
disorders, including giardiasis, reduction in villus-to-crypt ra-
tios correlates with impairments of digestion and absorption
(12, 13). More research is needed to evaluate the role of the
altered villus-crypt architecture in the development of IBS and
its possible consequences for nutrient digestion and absorption
at the time of visceral hypersensitivity, as postulated previ-
ously (26, 32).
IBS has been associated with increased numbers of mucosal
mast cells and IELs in some studies and not in others (2, 5, 15).
While the role of IELs in the pathophysiology of IBS remains
unclear, mast cell tryptase and trypsin are well-established
pathophysiological mediators of the activation of enteric cho-
linergic motor neurons and visceral pain in this disease (4, 5,
16). In addition, proteases combined with environmental fac-
tors, including stress, have been proposed to exacerbate vis-
ceral hypersensitivity after bacteria-induced colitis (38, 39).
Previous research also demonstrated that mucosal, as well as
connective tissue, mast cells were increased in giardiasis in
association with increased molecular uptake by the mucosa
(37). Consistent with these and other recent observations, the
data reported here indicate that IEL and mast cell counts were
increased in the jejunum of animals infected with Giardia of
Fig. 7. Infiltration of commensal bacteria
into the colonic mucosa during the infectious
stages (7, 21, and 50 days PI): representative
micrographs of bacterial infiltration into the
rat colonic mucosa. All colonic segments
were subjected to fluorescence in situ hybrid-
ization (FISH) with EUB338 probe, specific
for the domain bacteria (16S rRNA). Bacte-
ria were detected in the crypts, epithelial
layer, and lamina propria of infected rats, but
not in vehicle-treated animals. Host nuclei
(4=,6-diamidino-2-phenylindole) stained red,
and FISH-positive cells stained green
(EUB338-Cy3). Scale bars  50 m, mag-
nification 200. Note bacterial infiltration in
the mucosa (yellow asterisk) and microbiota
in direct contact with the mucosa in Giardia-
infected segment at 21 and 50 days PI.
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either assemblage, long after the parasite was cleared by the
host (5, 31, 37, 46, 78). Elevated mucosal mast cell numbers
have also been associated with increased levels of substance P
and vasoactive intestinal peptide, both important mediators of
diarrhea-predominant IBS in humans, as well as in rats (73). A
recent report indicates that mast cells and nerve growth factor
may play a key role in visceral hypersensitivity (80). Interest-
ingly, however, the rectal hypersensitivity observed in our
model did not correlate with IEL and mast cell hyperplasia.
These observations are consistent with markers of IBS in
patients in the presence or absence of inflammation (2, 5, 15).
The findings reported here offer further support to the hypoth-
esis that, while not absolutely required, elevated mast cell and
IEL numbers in the mucosa may contribute to the pathophys-
iology of postgiardiasis IBS. Further studies using mast cell
degranulation inhibitors or antagonists or mast cell stabilizers
such compound 48/80 or doxantrazole, as described previously
(49), will help confirm the role of mast cells in this model. In
an attempt to further characterize the nociceptive signaling
pathway involved in postgiardiasis visceral hypersensitivity,
additional experiments assessed the expression of c-fos, a
marker of nociceptive signaling known to be implicated in IBS
(30, 82). The protein c-Fos is a nuclear transcription factor of
genes involved in the adaptive response to painful stimuli (61).
The results shown here demonstrate that c-fos expression is
increased in the thoracolumbar section of the spinal cord in
animals infected with Giardia during the acute stage of the
disease (at 7 days), upon parasite clearance (at 21 days), and
postinfectiously (at 50 days). Consistent with these findings,
Fig. 8. G. duodenalis assemblage A facilitates the translocation of noninvasive
Escherichia coli HB101 across confluent intestinal epithelial monolayers:
translocation of a noninvasive E. coli HB101 through confluent Caco-2
monolayers on 3.0-m-pore Transwell filter. Values represent the number of
colony-forming units (CFUs) recovered from the basolateral compartment of
the Transwell filter after incubation with E. coli HB101 alone or both Giardia
and E. coli HB101 up to 6 h postexposure. Values are means 
 SE of 4
independent experiments, where groups were tested in triplicate (n 9 in each
group). *P  0.05 (by Student’s t-test and Newman-Keuls test). Increase in
bacterial translocation was significantly different in the presence of Giardia at
2, 3, and 6 h of incubation.
Fig. 9. G. duodenalis assemblage A does not induce E. coli HB101 internal-
ization in confluent Caco-2 monolayers: internalization of a noninvasive E. coli
HB101 in Caco-2 monolayers exposed to E. coli or Giardia 	 E. coli for up
to 6 h. Values are means 
 SE of 4 independent experiments, where each
group was tested in triplicate. No significant difference was observed between
Giardia- and E. coli-treated groups (by Student’s t-test and Newman-Keuls
test).
Fig. 10. G. duodenalis induces degradation of the tight junction protein
occludin at 1, 2, 3, and 6 h postexposure: immunoblotting analysis of tight
junction protein expression on standardized protein concentration (3 mg/ml).
Ponceau red staining was used as loading control.
Fig. 11. G. duodenalis induces degradation of the tight junction protein
claudin-4 at 1, 2, 3, and 6 h postexposure: immunoblotting analysis of tight
junction protein expression on standardized protein concentration (3 mg/ml).
Ponceau red staining was used as loading control.
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intraperitoneal administration of a mast cell mediator has been
found to activate c-fos in the dorsal horn neurons (48). Further
research is needed to dissect the respective roles of mast cells
and IELs in postinfectious visceral hypersensitivity, as prolif-
eration of these immune cells appeared to be site-specific and
to coincide with postinfectious c-fos expression, but not c-fos
expression during the acute phase of the infection.
Another set of experiments further established whether post-
giardiasis visceral hypersensitivity in this model was associ-
ated with other intestinal abnormalities linked to IBS in other
studies. Intestinal microbiota play a key role in health and
disease (72), and IBS has been associated with microbiota
dysbiosis (21) and small intestinal bacterial overgrowth (62,
65). Moreover, we recently demonstrated that Giardia infec-
tion alters the host microbiota at a structural and a composi-
tional level (6). Finally, numerous studies have also observed
intestinal barrier dysfunction during IBS (63) and Giardia
infection (18, 71). Results from the present experiments in vivo
demonstrate that, indeed, Giardia induces the translocation of
commensal bacteria during the acute stage of infection as well
as postinfection, laying the foundations for other studies that
will help identify pathogenic mechanisms of microbiota dys-
biosis in PI-IBS. Indeed, bacterial translocation has been
shown to trigger a macrophage-driven cytokine cascade that
drives local inflammatory reaction and generates responses
such as hyperalgesia and rectal hypersensitivity (20, 79). In
addition, bacterial endotoxins have been shown to induce fos
immunoreactivity (28). In the present experiments, FISH anal-
ysis revealed translocated bacteria in the infected colon, a site
far from the active colonization by the parasitic trophozoites.
FISH analysis also illustrated that the microbiota of Giardia-
infected animals were closely apposed to the epithelial surface
of the intestine, unlike those in vehicle-treated animals, where
the commensal microorganisms were clearly separated from
the host tissues by the space normally occupied by the host
mucus lining. More research is warranted to determine whether
and how Giardia may affect the intestinal mucus barrier and
whether giardiasis may favor the development of mucolytic
bacteria, as suggested in IBD (64).
Additional studies were performed in vitro in an attempt to
characterize the mechanisms leading to the Giardia-induced
loss of epithelial barrier function associated with postinfectious
visceral hypersensitivity. Human colonic epithelial Caco-2 cell
monolayers were exposed to Giardia assemblage A trophozo-
ites with noninvasive E. coli HB101 meant to reflect what may
happen to commensal bystanders during infection. Giardia
promoted the translocation of noninvasive E. coli through the
confluent epithelial monolayer. Short coincubation times of 2 h
were sufficient for Giardia to induce the translocation of these
bacteria. Giardia does not appear to induce internalization and
subsequent transcellular passage of noninvasive E. coli, unlike
the abnormalities induced by other enteropathogens such as C.
jejuni (42).
Studies have shown that epithelial tight junctions are dis-
rupted during IBS (10, 56), and Giardia duodenalis has been
reported to degrade proteins of the apical junction complex
such as zonula occludens-1, occludin, F-actin, -actinin, E-
cadherin, and claudin-1 (52, 71, 75). Consistent with these
observations, the present results demonstrate that, indeed,
increased bacterial translocation correlated with G. duode-
nalis-induced degradation of at least two transmembrane
tight junction proteins, occludin and claudin-4, regardless of
the presence or absence of noninvasive E. coli. Hence, this
phenomenon can be caused by Giardia alone and does not
require parasite interaction with commensal bacteria.
In conclusion, using a novel model system with the human
enteropathogen G. duodenalis, we have established, for the
first time, a cause-and-effect relationship between giardiasis
and the development of postinfectious visceral hypersensitiv-
ity. This hypersensitivity occurred at the site of infection, as
well as in areas of the GI tract such as the rectum, which is not
colonized by the inciting enteropathogen, similar to hypersen-
sitivity in patterns observed in human PI-IBS. Coinciding with
Giardia-induced translocation of commensal bacteria during
the acute and postinfectious stages of giardiasis, nociceptive
c-fos is activated in the spinal dorsal horn. In association with
these abnormalities, villus-crypt alterations and proliferation of
mast cells and IELs could be detected in the jejunum, but not
in the rectum. Finally, Giardia-induced translocation of com-
mensal bacteria appears to favor the paracellular route, in
conjunction with the degradation of the tight junction proteins
occludin and claudin-4. Taken together, the findings point to
key pathways whereby giardiasis may cause PI-IBS.
GRANTS
These studies were funded by the Natural Sciences and Engineering
Research Council of Canada (Discovery and CREATE grant programs) and the
French-Canada Collaborative Research Program. M. C. M. Halliez was spon-
sored by a French National Research Scholarship.
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the authors.
AUTHOR CONTRIBUTIONS
M.C.M.H., J.-P.M., L.F., G. Gargala, T.K.L., C.A., and A.G.B. developed
the concept and designed the research; M.C.M.H., T.D.F., G. Guerin, L.L.,
A.F., and E.C. performed the experiments; M.C.M.H., J.-P.M., and A.G.B.
analyzed the data; M.C.M.H. interpreted the results of the experiments;
M.C.M.H. prepared the figures; M.C.M.H. drafted the manuscript; M.C.M.H.,
J.-P.M., and A.G.B. edited and revised the manuscript; M.C.M.H., J.-P.M.,
T.D.F., L.L., A.F., L.F., G. Gargala, T.K.L., C.A., and A.G.B. approved the
final version of the manuscript.
REFERENCES
1. Arebi N, Gurmany S, Bullas D, Hobson A, Stagg A, Kamm M. The
psychoneuroimmunology of irritable bowel syndrome—an exploration of
interactions between psychological, neurological and immunological ob-
servations. Aliment Pharmacol Ther 28: 830–840, 2008.
2. Arévalo F, Aragon V, Montes P, Guzmán E, Monge E. [Increase of
intraepithelial lymphocytes in patients with irritable bowel syndrome]. Rev
Gastroenterol Perú 31: 315–318, 2011.
3. Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J,
Spiller RC. Mechanisms of hypersensitivity in IBS and functional disor-
ders. Neurogastroenterol Motil 19: 62–88, 2007.
4. Balestra B, Vicini R, Cremon C, Zecchi L, Dothel G, Vasina V, De
Giorgio R, Paccapelo A, Pastoris O, Stanghellini V, Corinaldesi R, De
Ponti F, Tonini M, Barbara G. Colonic mucosal mediators from patients
with irritable bowel syndrome excite enteric cholinergic motor neurons.
Neurogastroenterol Motil 24: 1118–e570, 2012.
5. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS,
Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett
NW, Collins SM, Corinaldesi R. Activated mast cells in proximity to
colonic nerves correlate with abdominal pain in irritable bowel syndrome.
Gastroenterology 126: 693–702, 2004.
6. Beatty JK, Akierman S, Rioux K, Beck P, McKnight W, Feener T,
Wallace J, Buret A. Gut microbiota biofilm disruptions by Giardia:
pathology in human enterocytes and germ-free mice (Abstract). FASEB J
27: 131.1, 2013.
G583MECHANISMS OF POSTGIARDIASIS VISCERAL HYPERSENSITIVITY
AJP-Gastrointest Liver Physiol • doi:10.1152/ajpgi.00144.2015 • www.ajpgi.org
7. Beatty JK, Bhargava A, Buret AG. Post-infectious irritable bowel
syndrome: mechanistic insights into chronic disturbances following en-
teric infection. World J Gastroenterol 20: 3976–3985, 2014.
8. Bénéré E, Van Assche T, Van Ginneken C, Peulen O, Cos P, Maes L.
Intestinal growth and pathology of Giardia duodenalis assemblage sub-
type AI, AII, B and E in the gerbil model. Parasitology 139: 424–433,
2012.
9. Bercík P, Wang L, Verdú EF, Mao YK, Blennerhassett P, Khan WI,
Kean I, Tougas G, Collins SM. Visceral hyperalgesia and intestinal
dysmotility in a mouse model of postinfective gut dysfunction. Gastroen-
terology 127: 179–187, 2004.
10. Bertiaux-Vandaële N, Youmba SB, Belmonte L, Lecleire S, Antonietti
M, Gourcerol G, Leroi AM, Déchelotte P, Ménard JF, Ducrotté P,
Coëffier M. The expression and the cellular distribution of the tight
junction proteins are altered in irritable bowel syndrome patients with
differences according to the disease subtype. Am J Gastroenterol 106:
2165–2173, 2011.
11. Buret A, denHollander N, Wallis PM, Befus D, Olson ME. Zoonotic
potential of giardiasis in domestic ruminants. J Infect Dis 162: 231–237,
1990.
12. Buret A, Gall DG, Olson ME. Effects of murine giardiasis on growth,
intestinal morphology, and disaccharidase activity. J Parasitol 76: 403–
409, 1990.
13. Buret A, Gall DG, Olson ME. Growth, activities of enzymes in the small
intestine, and ultrastructure of microvillous border in gerbils infected with
Giardia duodenalis. Parasitol Res 77: 109–114, 1991.
14. Buret A, Hardin JA, Olson ME, Gall DG. Pathophysiology of small
intestinal malabsorption in gerbils infected with Giardia lamblia. Gastro-
enterology 103: 506–513, 1992.
15. Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods,
mechanisms, and pathophysiology. The confluence of increased permea-
bility, inflammation, and pain in irritable bowel syndrome. Am J Physiol
Gastrointest Liver Physiol 303: G775–G785, 2012.
16. Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G,
Andrade-Gordon P, Steinhoff M, Barbara G, Beck P, Bunnett NW,
Sharkey KA, Ferraz JG, Shaffer E, Vergnolle N. Role for protease
activity in visceral pain in irritable bowel syndrome. J Clin Invest 117:
636–647, 2007.
17. Cevallos A, Carnaby S, James M, Farthing JG. Small intestinal injury
in a neonatal rat model of giardiasis is strain dependent. Gastroenterology
109: 766–773, 1995.
18. Chen TL, Chen S, Wu HW, Lee TC, Lu YZ, Wu LL, Ni YH, Sun CH,
Yu WH, Buret AG, Yu LC. Persistent gut barrier damage and commen-
sal bacterial influx following eradication of Giardia infection in mice. Gut
Pathog 5: 26, 2013.
19. Clarke G, Quigley EM, Cryan JF, Dinan TG. Irritable bowel syndrome:
towards biomarker identification. Trends Mol Med 15: 478–489, 2009.
20. Coelho AM, Fioramonti J, Buéno L. Systemic lipopolysaccharide influ-
ences rectal sensitivity in rats: role of mast cells, cytokines, and vagus
nerve. Am J Physiol Gastrointest Liver Physiol 279: G781–G790, 2000.
21. Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol
11: 497–505, 2014.
22. Costantini M, Sturniolo GC, Zaninotto G, D’Inca` R, Polo R, Nacca-
rato R, Ancona E. Altered esophageal pain threshold in irritable bowel
syndrome. Dig Dis Sci 38: 206–212, 1993.
23. Cotton JA, Beatty JK, Buret AG. Host parasite interactions and patho-
physiology in Giardia infections. Int J Parasitol 41: 925–933, 2011.
24. Diamond LS, Harlow DR, Cunnick CC. A new medium for the axenic
cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc
Trop Med Hyg 72: 431–432, 1978.
25. Evans PR, Bennett EJ, Bak YT, Tennant CC, Kellow JE. Jejunal
sensorimotor dysfunction in irritable bowel syndrome: clinical and psy-
chosocial features. Gastroenterology 110: 393–404, 1996.
26. Evans PR, Piesse C, Bak YT, Kellow JE. Fructose-sorbitol malabsorp-
tion and symptom provocation in irritable bowel syndrome: relationship to
enteric hypersensitivity and dysmotility. Scand J Gastroenterol 33: 1158–
1163, 1998.
27. Fent J, Balázs L, Buzás G, Erasmus LP, Hölzl R, Kovács A, Weisz J,
Adám G. Colonic sensitivity in irritable bowel syndrome and normal
subjects according to their hemispheric preference and cognitive style.
Integr Physiol Behav Sci 34: 54–62, 1999.
28. Gaykema RP, Goehler LE, Tilders FJ, Bol JG, McGorry M, Fleshner
M, Maier SF, Watkins LR. Bacterial endotoxin induces fos immunore-
activity in primary afferent neurons of the vagus nerve. Neuroimmuno-
modulation 5: 234–240, 1998.
29. Geurden T, Geldhof P, Levecke B, Martens C, Berkvens D, Casaert S,
Vercruysse J, Claerebout E. Mixed Giardia duodenalis assemblage A
and E infections in calves. Int J Parasitol 38: 259–264, 2008.
30. Gibney SM, Gosselin RD, Dinan TG, Cryan JF. Colorectal distension-
induced prefrontal cortex activation in the Wistar-Kyoto rat: implications
for irritable bowel syndrome. Neuroscience 165: 675–683, 2010.
31. Gillon J, Al Thamery D, Ferguson A. Features of small intestinal
pathology (epithelial cell kinetics, intraepithelial lymphocytes, disaccha-
ridases) in a primary Giardia muris infection. Gut 23: 498–506, 1982.
32. Goldstein R, Braverman D, Stankiewicz H. Carbohydrate malabsorp-
tion and the effect of dietary restriction on symptoms of irritable bowel
syndrome and functional bowel complaints. Isr Med Assoc J 2: 583–587,
2000.
33. Halliez MC, Buret AG. Extra-intestinal and long term consequences of
Giardia duodenalis infections. World J Gastroenterol 19: 8974–8985,
2013.
34. Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel
syndrome—a meta-analysis. Am J Gastroenterol 101: 1894–1899; quiz
1942, 2006.
35. Hanevik K, Dizdar V, Langeland N, Hausken T. Development of
functional gastrointestinal disorders after Giardia lamblia infection. BMC
Gastroenterol 9: 27, 2009.
36. Hanevik K, Wensaas KA, Rortveit G, Eide GE, Mørch K, Langeland
N. Irritable bowel syndrome and chronic fatigue 6 years after Giardia
infection: a controlled prospective cohort study. Clin Infect Dis 59:
1394–1400, 2014.
37. Hardin JA, Buret AG, Olson ME, Kimm MH, Gall DG. Mast cell
hyperplasia and increased macromolecular uptake in an animal model of
giardiasis. J Parasitol 83: 908–912, 1997.
38. Ibeakanma C, Ochoa-Cortes F, Miranda-Morales M, McDonald T,
Spreadbury I, Cenac N, Cattaruzza F, Hurlbut D, Vanner S, Bunnett
N, Vergnolle N, Vanner S. Brain-gut interactions increase peripheral
nociceptive signaling in mice with postinfectious irritable bowel syn-
drome. Gastroenterology 141: 2098–2108, 2011.
39. Jacobson K, McHugh K, Collins S. The mechanism of altered neural
function in a rat model of acute colitis. Gastroenterology 112: 156–162,
1997.
40. Jawed H, Jamall S, Shah SU, Perveen K, Hanif F, Simjee SU.
N-(2-hydroxy phenyl) acetamide produces profound inhibition of c-Fos
protein and mRNA expression in the brain of adjuvant-induced arthritic
rats. Mol Cell Biochem 387: 81–90, 2014.
41. Jones R, Lydeard S. Irritable bowel syndrome in the general population.
BMJ 304: 87–90, 1992.
42. Kalischuk LD, Inglis GD, Buret AG. Campylobacter jejuni induces
transcellular translocation of commensal bacteria via lipid rafts. Gut
Pathog 1: 2, 2009.
43. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L,
Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of
irritable bowel syndrome patients differs significantly from that of healthy
subjects. Gastroenterology 133: 24–33, 2007.
44. Keister DB. Axenic culture of Giardia lamblia in TYI-S-33 medium
supplemented with bile. Trans R Soc Trop Med Hyg 77: 487–488, 1983.
45. Kellow JE, Phillips SF, Miller LJ, Zinsmeister AR. Dysmotility of the
small intestine in irritable bowel syndrome. Gut 29: 1236–1243, 1988.
46. Khaldi S, Gargala G, Le Goff L, Parey S, Francois A, Fioramonti J,
Ballet JJ, Dupont JP, Ducrotté P, Favennec L. Cryptosporidium par-
vum isolate-dependent postinfectious jejunal hypersensitivity and mast
cell accumulation in an immunocompetent rat model. Infect Immun 77:
5163–5169, 2009.
47. Levecke B, Geldhof P, Claerebout E, Dorny P, Vercammen F, Cacciò
SM, Vercruysse J, Geurden T. Molecular characterisation of Giardia
duodenalis in captive non-human primates reveals mixed assemblage A
and B infections and novel polymorphisms. Int J Parasitol 39: 1595–1601,
2009.
48. Levy D, Kainz V, Burstein R, Strassman AM. Mast cell degranulation
distinctly activates trigemino-cervical and lumbosacral pain pathways and
elicits widespread tactile pain hypersensitivity. Brain Behav Immun 26:
311–317, 2012.
49. Li E, Zhao A, Shea-Donohue T, Singer SM. Mast cell-mediated changes
in smooth muscle contractility during mouse giardiasis. Infect Immun 75:
4514–4518, 2007.
G584 MECHANISMS OF POSTGIARDIASIS VISCERAL HYPERSENSITIVITY
AJP-Gastrointest Liver Physiol • doi:10.1152/ajpgi.00144.2015 • www.ajpgi.org
50. Li WM, Suzuki A, Cui KM. Responses of blood pressure and renal
sympathetic nerve activity to colorectal distension in anesthetized rats. J
Physiol Sci 56: 153–156, 2006.
51. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable
bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 10: 712–
721, 2012.
52. Maia-Brigagão C, Morgado-Díaz JA, De Souza W. Giardia disrupts the
arrangement of tight, adherens and desmosomal junction proteins of
intestinal cells. Parasitol Int 61: 280–287, 2012.
53. Marshall JK, Thabane M, Borgaonkar MR, James C. Postinfectious
irritable bowel syndrome after a food-borne outbreak of acute gastroen-
teritis attributed to a viral pathogen. Clin Gastroenterol Hepatol 5:
457–460, 2007.
54. Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins
SM, Walkerton Health Study Investigators. Eight year prognosis of
postinfectious irritable bowel syndrome following waterborne bacterial
dysentery. Gut 59: 605–611, 2010.
55. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins
SM, Walkerton Health Study Investigators. Incidence and epidemiol-
ogy of irritable bowel syndrome after a large waterborne outbreak of
bacterial dysentery. Gastroenterology 131: 445–450, 2006.
56. Martínez C, Vicario M, Ramos L, Lobo B, Mosquera JL, Alonso C,
Sánchez A, Guilarte M, Antolín M, de Torres I, González-Castro AM,
Pigrau M, Saperas E, Azpiroz F, Santos J. The jejunum of diarrhea-
predominant irritable bowel syndrome shows molecular alterations in the
tight junction signaling pathway that are associated with mucosal patho-
biology and clinical manifestations. Am J Gastroenterol 107: 736–746,
2012.
57. McLean PG, Picard C, Garcia-Villar R, Moré J, Fioramonti J, Buéno
L. Effects of nematode infection on sensitivity to intestinal distension: role
of tachykinin NK2 receptors. Eur J Pharmacol 337: 279–282, 1997.
58. Mearin F, Pérez-Oliveras M, Perelló A, Vinyet J, Ibañez A, Coderch
J, Perona M. Dyspepsia and irritable bowel syndrome after a Salmonella
gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterol-
ogy 129: 98–104, 2005.
59. Meleine M, Matricon J. Gender-related differences in irritable bowel
syndrome: potential mechanisms of sex hormones. World J Gastroenterol
20: 6725–6743, 2014.
60. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal
perception is a biological marker of patients with irritable bowel syn-
drome. Gastroenterology 109: 40–52, 1995.
61. Morgan JI, Curran T. Inducible proto-oncogenes of the nervous system:
their contribution to transcription factors and neuroplasticity. Prog Brain
Res 86: 287–294, 1990.
62. O’Leary C, Quigley EM. Small bowel bacterial overgrowth, celiac
disease, and IBS: what are the real associations? Am J Gastroenterol 98:
720–722, 2003.
63. Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R,
Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP,
Neunlist M. Impaired intestinal barrier integrity in the colon of patients
with irritable bowel syndrome: involvement of soluble mediators. Gut 58:
196–201, 2009.
64. Png CW, Lindén SK, Gilshenan KS, Zoetendal EG, McSweeney CS,
Sly LI, McGuckin MA, Florin TH. Mucolytic bacteria with increased
prevalence in IBD mucosa augment in vitro utilization of mucin by other
bacteria. Am J Gastroenterol 105: 2420–2428, 2010.
65. Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M.
Small intestinal bacterial overgrowth in patients with irritable bowel
syndrome. Gut 56: 802–808, 2007.
66. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon
in the irritable colon syndrome. Gut 14: 125–132, 1973.
67. Romero-Calvo I, Ocón B, Martínez-Moya P, Suárez MD, Zarzuelo A,
Martínez-Augustin O, de Medina FS. Reversible Ponceau staining as a
loading control alternative to actin in Western blots. Anal Biochem 401:
318–320, 2010.
68. Roxström-Lindquist K, Palm D, Reiner D, Ringqvist E, Svärd SG.
Giardia immunity—an update. Trends Parasitol 22: 26–31, 2006.
69. Saleh TM, Connell BJ, Allen GV. Visceral afferent activation-induced
changes in sympathetic nerve activity and baroreflex sensitivity. Am J
Physiol Regul Integr Comp Physiol 276: R1780–R1791, 1999.
70. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the com-
parative CT method. Nat Protoc 3: 1101–1108, 2008.
71. Scott KG, Meddings JB, Kirk DR, Lees-Miller SP, Buret AG. Intes-
tinal infection with Giardia spp. reduces epithelial barrier function in a
myosin light chain kinase-dependent fashion. Gastroenterology 123:
1179–1190, 2002.
72. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health
and disease. Physiol Rev 90: 859–904, 2010.
73. Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi
HS, Sim J, Jang KS. Mast cell number, substance P and vasoactive
intestinal peptide in irritable bowel syndrome with diarrhea. Scand J
Gastroenterol 49: 43–51, 2014.
74. Sundin J, Rangel I, Kumawat AK, Hultgren-Hörnquist E, Brummer
RJ. Aberrant mucosal lymphocyte number and subsets in the colon of
post-infectious irritable bowel syndrome patients. Scand J Gastroenterol
49: 1068–1075, 2014.
75. Teoh DA, Kamieniecki D, Pang G, Buret AG. Giardia lamblia rear-
ranges F-actin and -actinin in human colonic and duodenal monolayers
and reduces transepithelial electrical resistance. J Parasitol 86: 800–806,
2000.
76. Thabane M, Kottachchi DT, Marshall JK. Systematic review and
meta-analysis: the incidence and prognosis of post-infectious irritable
bowel syndrome. Aliment Pharmacol Ther 26: 535–544, 2007.
77. Thabane M, Simunovic M, Akhtar-Danesh N, Garg AX, Clark WF,
Collins SM, Salvadori M, Marshall JK. An outbreak of acute bacterial
gastroenteritis is associated with an increased incidence of irritable bowel
syndrome in children. Am J Gastroenterol 105: 933–939, 2010.
78. Walker MM, Talley NJ, Prabhakar M, Pennaneac’h CJ, Aro P,
Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agreus L.
Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as
possible disease markers in the irritable bowel syndrome and functional
dyspepsia. Aliment Pharmacol Ther 29: 765–773, 2009.
79. Wang B, Glatzle J, Mueller MH, Kreis M, Enck P, Grundy D.
Lipopolysaccharide-induced changes in mesenteric afferent sensitivity of
rat jejunum in vitro: role of prostaglandins. Am J Physiol Gastrointest
Liver Physiol 289: G254–G260, 2005.
80. Willot S, Gauthier C, Patey N, Faure C. Nerve growth factor content is
increased in the rectal mucosa of children with diarrhea-predominant
irritable bowel syndrome. Neurogastroenterol Motil 24: 734–739, e347,
2012.
81. World Health Organization. Guidelines for Drinking-Water Quality —
Volume 1: Recommendations (3rd ed., incorporating first and second
addenda). Geneva: World Health Organization, 2008. http://www.who.int/
water_sanitation_health/dwq/gdwq3/en/.
82. Zhang R, Zou N, Li J, Lv H, Wei J, Fang XC, Qian JM. Elevated
expression of c-fos in central nervous system correlates with visceral
hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS
treatment. Int J Colorectal Dis 26: 1035–1044, 2011.
G585MECHANISMS OF POSTGIARDIASIS VISCERAL HYPERSENSITIVITY
AJP-Gastrointest Liver Physiol • doi:10.1152/ajpgi.00144.2015 • www.ajpgi.org
